ZiBiPen

ZiBiPen
Product Description

ZiBiPen is the world's first reloadable epinephrine auto-injector, designed for reliability, affordability, and the assurance of being prepared. Instead of replacing the entire device annually, users simply reload a fresh cartridge in under two minutes while keeping the durable housing for years. This breakthrough addresses the recurring cost burden and environmental impact of single-use devices. Clinical studies demonstrate proven epinephrine delivery comparable to established auto-injectors, with 75% more first-time successes and 30 seconds faster to first dose versus leading single-use pens in simulated emergency scenarios. The design features automatic needle shielding, customizable needle depths for different body types, and an intuitive two-step activation process. ZiBiPen is 88% more affordable over a 5-year period and prevents massive plastic waste. We're seeking commercial partners for fill-finish manufacturing and global market launch. Start reloading. Stop replacing.

Impulse Biomedical

  • Country/Region:
    South Africa
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Medical Devices
Specifications
  • Selling Points
    Anti-Allergens; Green Product; Product Features; Product Performance; Sustainability; ZiBiPen delivers 88% cost savings over five years compared to single-use devices, making life-saving epinephrine accessible to more patients. Clinical performance shows 75% more first-time successes and 30 seconds faster to dose in simulated emergency use versus leading competitors. The reloadable cartridge system enables fresh medication in under two minutes at home, with usability studies confirming high user confidence. Safety features include 12x lower injury risk through automatic post-injection needle shielding and clear visual expiry indicators. Customizable needle depths accommodate different body types for optimal intramuscular delivery. Environmental impact is significant, with potential to save 122 million plastic bottles through reloadability. The device features ergonomic design and simple two-step activation. Globally patented technology offers flexible partnership models for licensing, distribution, or co-development across key markets.
  • Supplied from
    South Africa

Impulse Biomedical

  • Country/Region:
    South Africa
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Medical Devices